MR. JONATHAN LEE COHEN, MOT, OTR/L, SIPT
Occupational Therapy at Central Expy, Dallas, TX
License number
Texas 0006886
Category
Restorative Service Providers
Type
Pediatrics
License number
Texas 112946
Category
Restorative Service Providers
Type
Occupational Therapist
Address
Address
2
12222 N Central Expy SUITE 115, Dallas, TX 75243
2708 Black Sage Dr, Plano, TX 75093
2708 Black Sage Dr, Plano, TX 75093
Phone
(972) 546-0411
(972) 559-1867 (Fax)
(561) 767-0082
(972) 559-1867 (Fax)
(561) 767-0082
Personal information
See more information about JONATHAN LEE COHEN at radaris.comName
Address
Phone
4504 Avenue B, Austin, TX 78751
Professional information
Health Care Business Consultant At Advanced Solutions
Position:
Occupational Therapist III Float at Baylor's Our Children's House, Health Care Business Consultant at Advanced Solutions
Location:
Dallas/Fort Worth Area
Industry:
Hospital & Health Care
Work:
Baylor's Our Children's House
- 8-Satelite Offices since Jul 2011
-
Occupational Therapist III Float
Advanced Solutions
since May 2001
-
Health Care Business Consultant
Baylor Health Care Systems
Mar 2009 - Jul 2011
-
Clinical Manager
Advanced Pediatric Systems
Nov 1998 - Mar 2009
-
COO
AMERICAN REHABILITATION SERVICES/ MARINER HEALTH SYSTEMS/PRISM HEALTH SYSTEMS
Jun 1997 - Nov 1998
-
Staff Occupational Therapist
DEVELOPMENTAL PEDIATRICS
May 1997 - Nov 1998
-
Staff Occupational Therapist
All Children's Hospital
May 1996 - May 1997
-
Occupational Therapist
Education:
Rockhurst University 1993 - 1996
Master, Occupational Therapy University of Missouri-Columbia 1988 - 1993
Bachelor of Science, Human Environmental Sciences; Environmental Design Parkway North Sr. 1984 - 1988
High School Diploma
Master, Occupational Therapy University of Missouri-Columbia 1988 - 1993
Bachelor of Science, Human Environmental Sciences; Environmental Design Parkway North Sr. 1984 - 1988
High School Diploma
Interests:
Ironman Triathlete, Furthering my understanding of how a dual degree in Human and Envirnmental Design and Occupational Therapy can be used together to facilitate a person's success.
Certifications:
National Board Certification of Occupational Therapy, NBCOT
Sensory Integration Praxis Test Certified, Sensory Integration International
Tomatis Certification, Tomatis Development S.A.
The Listening Program with Bone Conduction, Advanced Brain Technology
Sensory Integration Praxis Test Certified, Sensory Integration International
Tomatis Certification, Tomatis Development S.A.
The Listening Program with Bone Conduction, Advanced Brain Technology
Drug Screen For Identifying An Agent That Modulates Low Density Lipoprotein Receptor Adaptin-Ligand Binding
US Patent:
6465196, Oct 15, 2002
Filed:
Mar 13, 2001
Appl. No.:
09/804778
Inventors:
Helen H. Hobbs - Dallas TX
Christine K. Garcia - Dallas TX
Robert I. Barnes - Frisco TX
Jonathan Cohen - Dallas TX
Christine K. Garcia - Dallas TX
Robert I. Barnes - Frisco TX
Jonathan Cohen - Dallas TX
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
G01N 3353
US Classification:
435 71, 435 6, 436501
Abstract:
Low density lipoprotein receptor (LDRL) adaptin is a novel, key component of human cholesterol regulation, which provides a target for rational drug design and screening, therapeutic intervention, and diagnosis. Disclosed reagents include a variety of LDLR adaptin and LDLR adaptin PTB and CC domain compositions, including in vitro compositions comprising a natural human LDLR adaptin PTB domain and a ligand such as an NPXY (SEQ ID NO:7) peptide. These LDLR adaptin reagents are used, inter alia, in rational drug screening methods. The invention also provides polynucleotides encoding the subject LDLR adaptin polypeptides, including natural coding sequences, which may be used as probes or primers for detecting or amplifying LDLR adaptin genes and transcripts.
Jonathan Cohen - Plano, TX
Work:
Jonathan L. Cohen
Outpatient Manager/Level III-OT Float Rehab Systems of Boca Raton, P.A; d.b.a. Advanced Pediatric Systems - Margate, FL
COO Staff, Contract and Per Diem Therapist - Boca Raton, FL
Occupational Therapist
Outpatient Manager/Level III-OT Float Rehab Systems of Boca Raton, P.A; d.b.a. Advanced Pediatric Systems - Margate, FL
COO Staff, Contract and Per Diem Therapist - Boca Raton, FL
Occupational Therapist
Education:
Rockhurst University - Kansas City, MO
Master of Occupational Therapy University of MO - Columbia, MO
Bachelor of Science in Environmental Science & Design
Master of Occupational Therapy University of MO - Columbia, MO
Bachelor of Science in Environmental Science & Design
Skills:
Sensory Integration and Praxis Test Certified, Tomatis Certified, ABT Certified, IM Certified
Jonathan L Cohen, Dallas TX - OTR
Specialties:
Occupational Therapy, Pediatric Occupational Therapy
Address:
12222 N Central Expy SUITE 115, Dallas 75243
(972) 546-0411 (Phone), (972) 559-1867 (Fax)
(972) 546-0411 (Phone), (972) 559-1867 (Fax)
Languages:
English
Methods For Detecting An Increased Risk For Coronary Heart Disease
US Patent:
2008027, Nov 6, 2008
Filed:
May 2, 2008
Appl. No.:
12/151275
Inventors:
Jonathan C. Cohen - Dallas TX, US
Helen H. Hobbs - Dallas TX, US
Helen H. Hobbs - Dallas TX, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The invention relates generally to an allele on human chromosome 9 associated with increased risk for coronary heart disease and the use or detection of such an allele in determining whether a human has an increased risk for coronary heart disease. In one aspect, the invention relates to methods for detecting a predisposition or propensity or susceptibility for coronary heart disease in a human, comprising detecting the presence of an allele on human chromosome 9 that is associated with an increased risk for coronary heart disease in a human. Disclosed are methods and compositions for determining whether a person carries an allele associated with increased risk for coronary atherosclerosis by determining whether the person has an RA-CHR9 allele, such as by determining whether the person has an RA-CHR9 allele-associated single nucleotide polymorphism (SNP). The invention also relates to kits for detecting the presence of an allele on chromosome 9 associated with an increased risk for coronary heart disease.
Sequence Variations In Pnpla3 Associated With Hepatic Steatosis
US Patent:
2010005, Mar 4, 2010
Filed:
Sep 3, 2009
Appl. No.:
12/553330
Inventors:
Helen H. Hobbs - Dallas TX, US
Jonathan C. Cohen - Dallas TX, US
Jonathan C. Cohen - Dallas TX, US
International Classification:
C40B 30/00, C12Q 1/68
US Classification:
506 7, 435 6
Abstract:
Disclosed are methods of identifying a genetic variant in a person determined to have or be predisposed having a fatty liver by determining whether the person has PNPLA3-I148M. Also disclosed are methods of identifying a genetic variant in a person by determining whether the person has PNPLA3-I148M; and prescribing to the person a treatment to reduce liver fat or associated inflammation.
Common Allele On Chromosome 9 Associated With Coronary Heart Disease
US Patent:
7883851, Feb 8, 2011
Filed:
May 21, 2007
Appl. No.:
11/751563
Inventors:
Jonathan C. Cohen - Dallas TX, US
Helen H. Hobba - Dallas TX, US
Helen H. Hobba - Dallas TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
C12Q 1/68, C12P 19/34
US Classification:
435 6, 435 912
Abstract:
Disclosed are methods and compositions for determining whether a person carries an allele associated with increased risk for coronary atherosclerosis by determining whether the person has had RA-CHR9 allele, such as by determining whether the person has an RA-CHR9 allele-associated single nucleotide polymorphism (SNP).